Acceptance of SARS-CoV-2 Vaccination Among a Cohort of IBD Patients From Southern Italy: A Cross-Sectional Survey.
作者信息
Crispino Federica, Brinch Daniele, Carrozza Lucio, Cappello Maria
机构信息
Gastroenterology & Hepatology Section, PROMISE, University of Palermo, Palermo, Italy.
出版信息
Inflamm Bowel Dis. 2021 Oct 20;27(11):e134-e135. doi: 10.1093/ibd/izab133.
Abstract
摘要
相似文献
1
Acceptance of SARS-CoV-2 Vaccination Among a Cohort of IBD Patients From Southern Italy: A Cross-Sectional Survey.意大利南部一组炎症性肠病患者对严重急性呼吸综合征冠状病毒2疫苗的接受情况：一项横断面调查。
Inflamm Bowel Dis. 2021 Oct 20;27(11):e134-e135. doi: 10.1093/ibd/izab133.
2
SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease-Fear and Desire.炎症性肠病患者对SARS-CoV-2疫苗接种的恐惧与期望
Inflamm Bowel Dis. 2021 Oct 20;27(11):1858-1861. doi: 10.1093/ibd/izab150.
3
Ensuring High and Equitable COVID-19 Vaccine Uptake Among Patients With IBD.确保 IBD 患者的 COVID-19 疫苗高接种率和公平性。
Inflamm Bowel Dis. 2021 Oct 18;27(10):1703-1705. doi: 10.1093/ibd/izab114.
4
The educational role of IBD nurses in Italy in vaccinations: do not miss the moment for COVID-19.意大利炎症性肠病护士在疫苗接种方面的教育作用：不要错过 COVID-19 疫苗接种的时机。
Eur Rev Med Pharmacol Sci. 2021 Sep;25(17):5542-5546. doi: 10.26355/eurrev_202109_26666.
5
SARS-CoV-2 vaccine hesitancy among patients with rheumatic and musculoskeletal diseases: a message for rheumatologists.风湿性和肌肉骨骼疾病患者对新型冠状病毒2型疫苗的犹豫态度：给风湿病学家的启示
Ann Rheum Dis. 2021 Jul;80(7):953-954. doi: 10.1136/annrheumdis-2021-220059. Epub 2021 Feb 23.
6
SARS-CoV-2 vaccine acceptance among gastroenterologists and inflammatory bowel disease patients: VACUNEII project.胃肠病学家和炎症性肠病患者对 SARS-CoV-2 疫苗的接受度：VACUNEII 项目。
Gastroenterol Hepatol. 2022 Dec;45(10):737-741. doi: 10.1016/j.gastrohep.2021.08.004. Epub 2021 Aug 25.
7
COVID-19 vaccination in patients with α1-antitrypsin deficiency.α1抗胰蛋白酶缺乏症患者的新冠病毒疫苗接种
Lancet Respir Med. 2021 Aug;9(8):818-820. doi: 10.1016/S2213-2600(21)00271-X. Epub 2021 Jun 18.
8
The impact of SARS-CoV-2 variants on IBD management.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）变体对炎症性肠病管理的影响。
Lancet Gastroenterol Hepatol. 2021 May;6(5):343-344. doi: 10.1016/S2468-1253(21)00075-3. Epub 2021 Mar 10.
9
Quantifying the Impact of Public Perceptions on Vaccine Acceptance Using Behavioral Economics.利用行为经济学量化公众认知对疫苗接种接受度的影响。
Front Public Health. 2020 Dec 3;8:608852. doi: 10.3389/fpubh.2020.608852. eCollection 2020.
10
Covid-19 vaccination during Ramadan.斋月期间的新冠疫苗接种。
BMJ. 2021 Apr 1;373:n862. doi: 10.1136/bmj.n862.
引用本文的文献
1
Unreliable information and fear: Barriers to vaccination among IBD patients in China.不可靠信息与恐惧：中国炎症性肠病患者的疫苗接种障碍
Hum Vaccin Immunother. 2025 Dec;21(1):2446071. doi: 10.1080/21645515.2024.2446071. Epub 2025 Jan 24.
2
Role of gastroenterologists and healthcare providers in promoting COVID-19 immunization among individuals with inflammatory bowel disease: A systematic review and meta-analysis on a global scale.全球范围内胃肠病学家和医疗保健提供者在促进炎症性肠病患者 COVID-19 免疫接种中的作用：系统评价和荟萃分析。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2349319. doi: 10.1080/21645515.2024.2349319. Epub 2024 May 16.
3
A Practical Update on COVID-19 and Inflammatory Bowel Disease: COVID-19 Disease Risk and Vaccine Safety and Efficacy.新型冠状病毒肺炎与炎症性肠病实用最新进展：新型冠状病毒肺炎疾病风险及疫苗安全性与有效性
Gastroenterol Hepatol (N Y). 2024 Feb;20(2):88-97.
4
COVID-19 Immunization Rates in Patients with Inflammatory Bowel Disease Worldwide: A Systematic Review and Meta-Analysis.全球炎症性肠病患者的COVID-19免疫接种率：一项系统评价和荟萃分析
Vaccines (Basel). 2023 Sep 25;11(10):1523. doi: 10.3390/vaccines11101523.
5
Patients with IBD have a more cautious attitude towards COVID-19 vaccination.炎症性肠病患者对 COVID-19 疫苗接种持更谨慎的态度。
Front Immunol. 2023 Jan 18;13:1077308. doi: 10.3389/fimmu.2022.1077308. eCollection 2022.
6
Inflammatory bowel disease and COVID-19 outcomes: a meta-analysis.炎症性肠病与 COVID-19 结局：荟萃分析。
Sci Rep. 2022 Dec 9;12(1):21333. doi: 10.1038/s41598-022-25429-2.
7
Patients with inflammatory bowel disease are more hesitant about Coronavirus disease 2019 vaccination.炎症性肠病患者对2019冠状病毒病疫苗接种更为犹豫。
Front Med (Lausanne). 2022 Nov 15;9:1005121. doi: 10.3389/fmed.2022.1005121. eCollection 2022.
8
COVID-19 Vaccination Among Individuals With Inflammatory Bowel Disease: Perception, Efficacy, and Safety.炎症性肠病患者的新冠病毒疫苗接种：认知、疗效与安全性
Gastroenterol Hepatol (N Y). 2022 Jul;18(7):388-399.
9
Risk of adverse outcomes in inflammatory bowel disease patients infected with SARS-CoV-2: a systematic review and meta-analysis.SARS-CoV-2 感染对炎症性肠病患者不良结局风险的系统评价和荟萃分析。
Int J Colorectal Dis. 2022 Nov;37(11):2277-2289. doi: 10.1007/s00384-022-04265-w. Epub 2022 Oct 22.
10
Effectiveness and Safety of COVID-19 Vaccines in Patients With Inflammatory Bowel Disease.2019冠状病毒病疫苗在炎症性肠病患者中的有效性和安全性
Gastroenterol Hepatol (N Y). 2022 Mar;18(3):145-155.
Zotero 插件